PMV Pharmaceuticals Inc. (PMVP)
NASDAQ: PMVP
· Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT
PMV Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 44.13M | 51.34M | 40.88M | 48.81M | 49.35M | 48.48M | 38.53M | 52.06M | 68.21M | 142.94M | 108.3M | 99.85M | 87.09M | 115.77M | 172.47M | 176.64M | 189.42M | 208.78M |
Short-Term Investments | 98.15M | 109.05M | 128.58M | 134.03M | 164.39M | 150.28M | 165.35M | 149.86M | 118.88M | 86.49M | 132.76M | 159.01M | 190.34M | 167.22M | 124.7M | 131.01M | 128.93M | 122.71M |
Long-Term Investments | 6.03M | 5.43M | 13.84M | 15.1M | n/a | 15.12M | 25.5M | 36.18M | 31.76M | n/a | 2.5M | n/a | n/a | 11.77M | 16.91M | 18.6M | 20.61M | 16.89M |
Other Long-Term Assets | 248K | 237K | 235K | 242K | 182K | 182K | 190K | 180K | 181K | 314K | 313K | 307K | 308K | 221K | 221K | 218K | 201K | 1.02M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.04M | 3.11M | 6.2M | 6.78M | 5.87M | 822K | 4.35M | 3.38M | 3.33M | 3.84M | 5.95M | 822K | 822K | 822K | 822K | 822K | 822K | 3.46M |
Total Current Assets | 145.31M | 163.5M | 175.66M | 189.62M | 218.79M | 202.46M | 207.41M | 205.3M | 190.41M | 233.28M | 247.01M | 265.18M | 281.87M | 288.04M | 301.29M | 313.56M | 323.08M | 334.95M |
Property-Plant & Equipment | 1.26M | 1.44M | 1.55M | 18.54M | 18.57M | 19.11M | 19.05M | 19.37M | 19.86M | 20.37M | 20.49M | 19.5M | 18.39M | 14.97M | 13.15M | 11.8M | 12.02M | 1.52M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 7.54M | 7.11M | 15.63M | 33.88M | 18.75M | 34.42M | 44.74M | 55.73M | 51.8M | 20.68M | 23.3M | 19.81M | 18.7M | 26.97M | 30.28M | 30.62M | 32.83M | 19.44M |
Total Assets | 152.85M | 170.61M | 191.29M | 223.5M | 237.54M | 236.88M | 252.15M | 261.03M | 242.22M | 253.96M | 270.31M | 284.98M | 300.56M | 315.01M | 331.57M | 344.18M | 355.91M | 354.39M |
Account Payables | 2.6M | 3.59M | 6.58M | 2.06M | 4.53M | 859K | 3.24M | 1.68M | 3.49M | 1.77M | 3M | 4.83M | 3.35M | 4.86M | 3.19M | 1.28M | 2.37M | 1.25M |
Deferred Revenue | n/a | n/a | n/a | n/a | -1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 403K | n/a | n/a | n/a |
Short-Term Debt | 377K | n/a | 352K | n/a | 1.15M | n/a | 852K | n/a | 18K | 281K | n/a | 394K | 383K | 258K | 403K | 545K | 677K | 666K |
Other Current Liabilities | 5.58M | 2.78M | 5M | 10.26M | 1.85M | n/a | 4.59M | n/a | 5.21M | 6.41M | n/a | 3.08M | 4.76M | 4.55M | 4.43M | 3.31M | 1.62M | 1.4M |
Total Current Liabilities | 11.61M | 9.76M | 14.37M | 13.56M | 11.38M | 12.06M | 14.03M | 10.72M | 11.45M | 10.59M | 10.83M | 11.66M | 11.38M | 11.69M | 12.22M | 8.56M | 7.5M | 5.8M |
Long-Term Debt | 643K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 643K | 742K | 838K | 12.02M | 11.84M | 12.14M | 12.43M | 12.7M | 12.96M | 13.2M | 13.45M | 12.13M | 12.21M | 11.48M | 10.79M | 10.67M | 10.56M | 302K |
Total Liabilities | 12.25M | 10.5M | 15.21M | 25.59M | 23.22M | 24.2M | 26.46M | 23.41M | 24.41M | 23.79M | 24.28M | 23.79M | 23.59M | 23.16M | 23.01M | 19.23M | 18.06M | 6.1M |
Total Debt | 1.02M | 1.11M | 1.19M | 13.27M | 12.99M | 13.02M | 13.29M | 12.7M | 12.98M | 13.48M | 13.98M | 12.53M | 12.59M | 11.74M | 11.19M | 11.21M | 11.24M | 968K |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -407.36M | -386.15M | -368.71M | -345.71M | -326.49M | -325.27M | -310M | -294.25M | -277.61M | -260.17M | -241.04M | -221.7M | -203.47M | -186.16M | -167.73M | -149.37M | -134.36M | -121.48M |
Comprehensive Income | 21K | 84K | 139K | 410K | -185K | -129K | 224K | -355K | -328K | -116K | -445K | -1.02M | -1.02M | -666K | -78K | 14K | 7K | -13K |
Shareholders Equity | 140.6M | 160.11M | 176.08M | 197.91M | 214.31M | 212.68M | 225.69M | 237.61M | 217.81M | 230.17M | 246.03M | 261.19M | 276.97M | 291.84M | 308.56M | 324.95M | 337.85M | 348.3M |
Total Investments | 104.18M | 114.48M | 142.42M | 149.13M | 164.39M | 165.41M | 190.86M | 149.86M | 118.88M | 86.49M | 135.25M | 159.01M | 190.34M | 178.99M | 141.61M | 149.61M | 149.54M | 139.6M |